| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| kd025 | rho-associated protein kinase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lupus Erythematosus Systemic[MeSHID:D008180] Systemic Scleroderma[MeSHID:D012595] Psoriasis[MeSHID:D011565] Scleroderma[MeSHID:D012594] Arthritis Psoriatic[MeSHID:D015535] Rheumatoid Arthritis[MeSHID:D001172] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||